TRIPS waiver: there's more to the story than vaccine patents
By Jocelyn Bosse, Lecturer in Intellectual Property Law, University of Reading
Hyo Yoon Kang, Reader in Intellectual Property Law, University of Kent
Siva Thambisetty, Associate Professor of Intellectual Property Law, London School of Economics and Political Science
The US has backed a proposal to waive intellectual property relating to COVID measures – but global efforts need to go beyond vaccine patents.
Read complete article
© The Conversation
- Friday, May 7, 2021